Opk-88006
Preclinical
Opk-88006 is one of 2 therapeutic programs targeting MASH. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Competition
Competitive Landscape
2 competitors in MASH
#DrugCompanyPhaseTrials
1Rezdiffra
Madrigal PharmaceuticalsPhase 2
Opk-88006
OOPKO Health, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Opk-88006. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]
- Company
- OOPKO Health, Inc.